Modern concepts of the diagnosis and treatment of purpura fulminans

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 27, Issue 3, 2008, Pages 191-196

  Edlich, Richard F ^a   Cross, Catherine L ^a   Dahlstrom, Jill J ^a   Long III, William B ^a  

^a LEGACY EMANUEL HOSPITAL   (United States)

Author keywords

Acute infectious purpura fulminans; Antithrombin III; Idiopathic purpura fulminans; Neonatal purpura fulminans; Protein C; Protein S

Indexed keywords

ANTIBIOTIC AGENT; ANTITHROMBIN III; HEPARIN; IMMUNOGLOBULIN; PROTEIN C; PROTEIN S; THROMBOCYTE CONCENTRATE; WARFARIN;

AMPUTATION; CLINICAL FEATURE; CONTINUOUS INFUSION; DEBRIDEMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; FASCIOTOMY; FEVER; FULMINATING PURPURA; HEPARINIZATION; HUMAN; HYPERBARIC OXYGEN; IDIOPATHIC DISEASE; IMMUNOTHERAPY; INFECTION; MENINGOCOCCEMIA; MORTALITY; NEWBORN DISEASE; PATHOGENESIS; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN DEFICIENCY; REVIEW; THROMBOCYTOPENIA;

EID: 48149095673     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i3.30     Document Type: Review

References (19)

1. Nolan J, Sinclair R. Review of management of purpura fulminans and two case reports. Br J Anaesth. 2001;86:581-6.
2. Kondaveeti S, Hibberd ML, Booy R, Nadel S, Levin M. Effect of the factor V Leiden mutation on the severity of meningococcal disease. Pediatr Infect Dis J. 1999;18:893-6.
3. Andreasen TJ, Green SD,Childers BJ. Massive infectious soft-tissue injury: Diagnosis and management of necrotizing fasciitis and purpura fulminans. Plast Reconstr Surg. 2001;107:1025-34.
4. D'Cruz D, Cervera R, Olcay Aydintug A, Ahmed T, Font J, Hughes GR. Systemic lupus erthematosus evolving into systemic vasculitis: a report of five cases. Br J Rheumatol. 1993;32: 154-7.
5. DiScipio RG, Davie EW. Characterization of protein S, a gamma-carboxygultamic acid containing protein from bovine and human plasma. Biochemistry. 1979;18:899-904.
6. Gladson CL, Groncy P, Griffin JH. Coumarin necrosis, neonatal purpura fulminans, and protein C deficiency. Arch Dermatol. 1987;123:1701a-6a.
7. Brown DL, Greenhalgh DG, Warden GD. Purpura fulminans and transient protein Cand S deficiency. Arch Dermatol. 1998;124:119-23.
8. Nolan J, Sinclair R. Review of management of purpura fulminans and two case reports. Br J Anaesthesiol. 2001;86:581-6.
9. Madden RM, Gill JC, Marlar RA. Protein C and protein S levels in two patients with acquired purpura fulminans. Br J Haematol. 1990; 75:112-7.
10. Sen K, Angshumoy R. Management of Neonatal Purpura Fulminans with Severe Protein C Deficiency. Indian Pediat. 2006;43:542-5.
11. Levin M, Eley BS, Louis J, Cohen H, Young L, Heyderman RS: Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr. 1995; 27: 55-63.
12. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura Fulminans Due to Staphylococcus aureus. CID. 2005;40:948-50.
13. Crado PR, Bernardelli IM, Rivitti EA, Sotto MN, Vilella MA, Valente NY, Martins JE. Childhood-onset skin necrosis resulting protein C deficiency. J Eur Acad Dermatol Benerol. 2007;24:537-9.
14. Marlar RA, Montgomery RR, Broekmans AW. Diagnosis and treatment of homozygous protein C deficiency. report of the working party on homozygous protein c deficiency of the Subcommittee on Protein C and Protein S, International Committee on Throbosis and Haemostasis. J Pediatr. 1989;114:528-34.
15. Sheridan RL, Briggs SE, Remensnyder JP, Tompkins RG. Management strategy in purpura fulminans with multiple organ failure in children. Burns. 1996;22:53-6.
16. Warner PM, Kagan RJ, Yakuboff KP, Kemalyan N, Palmieri TL, Greenhalgh DG, Sheridan RL, Mozingo DW, Heimbach DM, Gibran NS, Engrav L, Saffle JR, Edelman LS, Warden GD. Current management of purpura fulminans: a multicenter study. J Burn Care Rehabil. 2003;24:119-26.
17. Manco-Johnson MJ, Knapp-Clevenger R. Activated protein C concentrate reverses purpura fulminans in severe genetic protein C deficiency. J Pediatr Hematol Oncol. 2004;26:25-7.
18. Smith OP, White B: Infectious purpura fulminans: caution needed in the use of protein C. Br J Haematol. 1999;106:253-4.
19. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, Talbot J, Low DE. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999;28:800-7.